Studies have shown that exosomal miR-224 drives tumor progression and invasiveness by directly targeting GNMT, and the serum expression of exosomal miR-224 is higher in HCC patients than in healthy individuals [261]. This evidence concerns the gene GNMT and hepatocellular carcinoma.